Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

S&P TSX Capped Composite...

US Dollar vs CAD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

null

Invivyd (NASDAQ:IVVD)
Historical Stock Chart
From Dec 2024 to Jan 2025

Click Here for more Invivyd Charts.

Invivyd (NASDAQ:IVVD)
Historical Stock Chart
From Jan 2024 to Jan 2025

Click Here for more Invivyd Charts.

Invivyd Inc News

Form 8-K - Current report
Friday 10 January 2025 (2 weeks ago) • Edgar (US Regulatory)

Invivyd Announces Continued Neutralizing Activity of PEMGARDA™ (pemivibart) Against Dominant SARS-CoV-2 Variant XEC
Friday 10 January 2025 (2 weeks ago) • GlobeNewswire Inc.

Form 8-K - Current report
Friday 27 December 2024 (4 weeks ago) • Edgar (US Regulatory)

Form 8-K - Current report
Monday 2 December 2024 (2 months ago) • Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Thursday 14 November 2024 (2 months ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Thursday 14 November 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 14 November 2024 (2 months ago) • Edgar (US Regulatory)

Invivyd Reports Third Quarter 2024 Financial Results and Recent Business Highlights
Thursday 14 November 2024 (2 months ago) • GlobeNewswire Inc.

Invivyd Announces New England Journal of Medicine Publishes Letter to the Editor Highlighting Immunobridging Pathway Leading to PEMGARDA™ (pemivibart) Emergency Use Authorization; Comments on Adjacent Third-Party Letter to the Editor
Thursday 14 November 2024 (2 months ago) • GlobeNewswire Inc.

Invivyd Announces Preprints Conveying CANOPY Phase 3 Clinical Trial Data Including Long-Term Protection Versus Recent JN.1 Sublineages at Low Residual Titers, and Describing a Novel Approach for Predicting Monoclonal Antibody Activity Were Uploaded to MedR
Tuesday 12 November 2024 (2 months ago) • GlobeNewswire Inc.

Invivyd to Participate in the Guggenheim Securities Healthcare Innovation Conference
Wednesday 6 November 2024 (3 months ago) • GlobeNewswire Inc.

Invivyd to Host Third Quarter 2024 Financial Results and Corporate Update Conference Call on November 14, 2024
Wednesday 6 November 2024 (3 months ago) • GlobeNewswire Inc.

More Invivyd Inc News Articles

TheGlobe com (PK)

Brookmount Explorations (PK)

Tonix Pharmaceuticals

Lightwave Logic

Accredited Solutions (PK)

Northwest Biotherapeutics (QB)

UAV Corpoation (PK)

Moon Equity (PK)

MineralRite (PK)

Elite Pharmaceuticals (QB)

Intergrated Cannabis Sol... (PK)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions